日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Questions and answers

What we know about the Omicron variant so far

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2021-11-30 18:15
Share
Share - WeChat
A medical worker prepares a dose of COVID-19 vaccine at a vaccination site in Pingxiang city, South China's Guangxi Zhuang autonomous region, Nov 16, 2021. [Xinhua/Cao Yiming]

Answers to commonly-asked questions about the Omicron variant of COVID-19.

Q: Where and when was Omicron first detected, and how far has it spread?

The B.1.1.529 variant was first identified in South Africa on Nov 9 and became the dominant strain in circulation in the Gauteng province of South Africa within two weeks. On Nov 26, the World Health Organization designated it the fifth variant of concern (VOC) and named it Omicron after the Greek letter. The virus did not necessarily originate in South Africa.

As of Nov 28, countries and regions including South Africa, Israel, Belgium, Italy, the United Kingdom, Austria and the Hong Kong Special Administrative Region, have reported cases of the new strain. No cases have been reported elsewhere in China as yet.

Q: How has it evolved?

Genome sequencing of the new variant shows that the number of mutations it carries are significantly higher than known strains in the past two years. These mutations are concentrated on the virus's spike protein.

Three scenarios likely explain its emergence:

1. The virus accumulated a large number of mutations through a persistent infection in an immunocompromised patient and spread as a new strain through a chance event;

2. The virus infected an animal group and as a result, evolved at a faster mutation rate. It then spilled over into the human population;

3. The new strain had already been circulating in places without sufficient monitoring systems for a long time, and earlier generations of the strain have been missed.

Q: Is it more transmissible?

There is no systematic data on the new strain's transmissibility, pathogenicity or its ability to evade immunity. But it contains key mutations observed in four other variants of concern — Alpha, Beta, Gamma and Delta — as well as mutations associated with the enhanced ability to bind to human cells and multiply.

Epidemiological studies and monitoring data points to a spike in Omicron infections in South Africa that threatens to replace the dominant Delta strain. More research is needed to determine contagiousness.

Q: What is the new strain's impact on vaccines and antibody treatment?

Research shows that three mutations on the virus's spike protein — K417N, E484A and N501Y — are linked to a stronger ability to evade immunity. Omicron carries all three, as well as other mutations that will likely diminish protection provided by antibody drugs.

More research is needed to determine its effect on existing vaccines.

Q: How about its impact on nucleic acid testing kits?

Genome sequencing analysis shows that the mutations will not affect the sensitivity and specificity of mainstream nucleic acid tests in China. Some laboratories in South Africa reported that testing kits being used there likely cannot detect the new strain effectively.

Q: What measures have been taken?

A number of countries and regions, including the United States, the United Kingdom, the European Union, Russia, Israel, the Hong Kong Special Administrative Region and Taiwan have restricted travel from South Africa.

Q: How is China responding?

China's strategy of preventing imported cases and swiftly dealing with local resurgences remains effective against the Omicron strain. The Chinese Center for Disease Control and Prevention has established testing methods for the new strain and will continuously sequence genomes of imported cases to catch possible infections in a timely manner.

Q: What can the public do to protect themselves against the new strain?

Wearing masks remains the most effective way to stem the spread of the virus, including the Omicron variant. It is recommended that all people, including the fully vaccinated and those receiving a booster shot, wear masks in indoor spaces and on public transportation. Regular hand washing and good ventilation are also important.

Given the limited understanding so far of the new strain and risk of infections in China, the public is recommended to avoid traveling to high-risk areas overseas and to step up personal protection during trips.

Source: National Health Commission

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 成年人国产网站 | 欧美综合精品 | 亚洲一区精品在线 | 国产精品欧美一区二区三区不卡 | 精品免费视频 | 亚洲已满18点击进入在线观看 | 色福利网 | av一级久久 | 狠狠色噜噜狠狠狠狠2018 | 日色网站 | 波多野结衣三级在线 | 三级特黄视频 | 国产国产成人久久精品杨幂 | 香港三级午夜理伦三级 | 国产欧美日韩综合精品一区二区 | 特黄特色的大片观看免费视频 | 久久精品视频在线观看 | 久草小视频 | 日韩黄色一级视频 | 中文线码中文高清播放中 | 91精品观看91久久久久久 | 日韩亚洲人成网站在线播放 | 日韩第一 | 免费国产一区二区在免费观看 | 日韩国产无矿砖一线二线图 | 国产日韩一区二区 | 日韩中文字幕网 | 高清在线不卡 | 奇米影视第七色 | 欧美国产中文字幕 | 三级网站日本 | 国产成人91 | 日本一区二区不卡 | 一级黄色片在线 | 国产小视频在线高清播放 | 国产精品视频免费观看 | 国产丫丫视频私人影院 | 久久久精品欧美 | 国产99久久久久久免费看 | 91av在线免费视频 | 国产成人在线播放视频 |